Literature DB >> 23703547

Changes in S-PSA after transurethral resection of prostate and its correlation to postoperative outcome.

Mrinal Pahwa1, Mayank Pahwa, Archna R Pahwa, Mohit Girotra, Arun Chawla, Ajay Sharma.   

Abstract

PURPOSE: Although different factors may affect prostate-specific antigen (PSA) reduction after transurethral resection of prostate, an approximate 70 % decrease from baseline is expected. We hereby undertook a prospective study to analyze changes in serum PSA (S-PSA) after transurethral resection of the prostate (TURP) and its correlation with the residual prostatic weight and clinical symptom score improvement.
METHODS: Seventy patients who underwent TURP for bladder outlet obstruction were included in the study. Patient's evaluation included history, International Prostate Symptom Score (IPSS), S-PSA, Qmax, post-void residual urine and prostate size. On follow-up, trans-rectal ultrasonography, S-PSA and IPSS score were calculated. Patients were analyzed in three groups based on the amount of tissue resected: less than 40, 40-60 and more than 60 % tissue resected.
RESULTS: Preoperative prostate size, IPSS, Qmax and S-PSA were 62.56 ml, 23.84, 11.68 ml/sec and 3.3 ng/ml. There was a significant decrease in the IPSS score, prostate size and S-PSA levels after TURP in all the three groups. There was a significant positive correlation of the amount of tissue resected with change in S-PSA levels, change in IPSS score and postoperative IPSS score. Reduction in IPSS score significantly correlated with patient's satisfaction.
CONCLUSIONS: The amount of tissue resected in TURP has a direct bearing on the S-PSA levels, change in symptom score and residual prostate volume. It is the percentage change in IPSS score and not the absolute value of IPSS, which has a direct bearing with the patient satisfaction and with the amount of tissue resected. Percentage fall in S-PSA by 70 % was found to be predictor of more than 60 % resection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23703547     DOI: 10.1007/s11255-013-0474-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

2.  Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip Van Kerrebroeck
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.

Authors:  V Scattoni; M Raber; F Montorsi; L Da Pozzo; M Brausi; G Calori; M Freschi; P Rigatti
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

5.  How complete is a transurethral resection of the prostate?

Authors:  J S Green; P Bose; D P Thomas; K Thomas; R Clements; W B Peeling; W G Bowsher
Journal:  Br J Urol       Date:  1996-03

6.  Prostatic tissue distal to the verumontanum and its significance for adenomatous recurrences after transurethral resection of the prostate. A cadaver study.

Authors:  A Kyriakidis; M Georgiadis; I Stiakakis; A Kyriakidis; A Koutselinis
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

7.  Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia.

Authors:  M Cetinkaya; E Ulusoy; T Aki; M Koşan; C Kundak; M M Aydos; S Gökkaya
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

8.  Predicted and actual change in serum PSA following prostatectomy for BPH.

Authors:  S N Lloyd; G N Collins; G B McKelvie; M Hehir; A C Rogers
Journal:  Urology       Date:  1994-04       Impact factor: 2.649

9.  Reference range of prostate-specific antigen after transurethral resection of the prostate.

Authors:  G Aus; S Bergdahl; R Frösing; P Lodding; E Pileblad; J Hugosson
Journal:  Urology       Date:  1996-04       Impact factor: 2.649

10.  Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia.

Authors:  Seyyed Yousef Hosseini; Mohammadreza Salimi; Seyyed Mohammad Mehdi Hosseini Moghaddam
Journal:  Urol J       Date:  2005       Impact factor: 1.510

View more
  2 in total

1.  Impact of perioperative factors on nadir serum prostate-specific antigen levels after holmium laser enucleation of prostate.

Authors:  Mary Martos; Jonathan E Katz; Madhumita Parmar; Anika Jain; Nachiketh Soodana-Prakash; Sanoj Punnen; Mark L Gonzalgo; Feng Miao; Isildinha M Reis; Nicholas Smith; Hemendra N Shah
Journal:  BJUI Compass       Date:  2021-01-05

Review 2.  Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction.

Authors:  Abhishek Bhat; Ruben Blachman-Braun; Thomas R W Herrmann; Hemendra N Shah
Journal:  World J Urol       Date:  2021-07-02       Impact factor: 3.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.